R. 1. Bjordal, J. Klovning, A. Ljunggren, A. Slordal, and L. , Short-term efficacy of pharmacotherapeutic interventions in osteoarthritic knee pain: A meta-analysis of randomised placebo-controlled trials, European Journal of Pain, vol.19, issue.11, pp.125-138, 2007.
DOI : 10.1016/j.ejpain.2006.02.013

D. Felson, Osteoarthritis of the Knee, New England Journal of Medicine, vol.354, issue.8, pp.841-848, 2006.
DOI : 10.1056/NEJMcp051726

N. Moore, Place of OTC analgesics and NSAIDs in osteoarthritis, InflammoPharmacology, vol.85, issue.4-6, pp.355-362, 2003.
DOI : 10.1163/156856003322699537

N. Moore, Diclofenac Potassium 12.5mg Tablets for Mild to Moderate Pain and Fever, Clinical Drug Investigation, vol.26, issue.10, pp.163-195, 2007.
DOI : 10.2165/00044011-200727030-00002

N. Moore, A. Charlesworth, E. Van-ganse, J. Leparc, J. Jones et al., Risk factors for adverse events in analgesic drug users: results from the PAIN study, Pharmacoepidemiology and Drug Safety, vol.94, issue.11, pp.601-610, 2003.
DOI : 10.1002/pds.842

N. Moore, E. Van-ganse, L. Parc, J. Wall, R. Schneid et al., The PAIN Study: Paracetamol, Aspirin and Ibuprofen New Tolerability Study, Clinical Drug Investigation, vol.18, issue.2, pp.89-98, 1999.
DOI : 10.2165/00044011-199918020-00001

D. Schaffer, T. Florin, C. Eagle, I. Marschner, G. Singh et al., Risk of serious NSAID-related gastrointestinal events during long-term exposure: a systematic review, Med J Aust, vol.185, pp.501-506, 2006.

G. Singh, O. Wu, P. Langhorne, and R. Madhok, Risk of acute myocardial infarction with nonselective non-steroidal anti-inflammatory drugs: a meta-analysis, Arthritis Research & Therapy, vol.8, issue.5, p.153, 2006.
DOI : 10.1186/ar2047

M. Wolfe, D. Lichtenstein, and G. Singh, Gastrointestinal Toxicity of Nonsteroidal Antiinflammatory Drugs, New England Journal of Medicine, vol.340, issue.24, pp.1888-1899, 1999.
DOI : 10.1056/NEJM199906173402407

O. Bruyere and J. Reginster, Glucosamine and Chondroitin Sulfate as Therapeutic Agents for Knee and Hip Osteoarthritis, Drugs & Aging, vol.47, issue.1, pp.573-580, 2007.
DOI : 10.2165/00002512-200724070-00005
URL : http://orbi.ulg.ac.be/jspui/handle/2268/19999

D. Clegg, D. Reda, C. Harris, M. Klein, O. Dell et al., Glucosamine, Chondroitin Sulfate, and the Two in Combination for Painful Knee Osteoarthritis, New England Journal of Medicine, vol.354, issue.8, pp.795-808, 2006.
DOI : 10.1056/NEJMoa052771

B. Mazieres, M. Hucher, M. Zaim, and P. Garnero, Effect of chondroitin sulphate in symptomatic knee osteoarthritis: a multicentre, randomised, double-blind, placebo-controlled study, Annals of the Rheumatic Diseases, vol.66, issue.5, pp.639-645, 2007.
DOI : 10.1136/ard.2006.059899

M. Hochberg and M. Dougados, Pharmacological therapy of osteoarthritis, Best Practice & Research Clinical Rheumatology, vol.15, issue.4, pp.583-593, 2001.
DOI : 10.1053/berh.2001.0175

S. Reichenbach, R. Sterchi, M. Scherer, S. Trelle, E. Burgi et al., Meta-analysis: Chondroitin for Osteoarthritis of the Knee or Hip, Annals of Internal Medicine, vol.146, issue.8, pp.580-590, 2007.
DOI : 10.7326/0003-4819-146-8-200704170-00009

R. Lagnaoui, M. Baumevielle, B. Begaud, P. Pouyanne, G. Maurice et al., Less Use of NSAIDs in Long-Term than in Recent Chondroitin Sulphate Users in Osteoarthritis: a Pharmacy-based Observational Study in France, Th??rapie, vol.61, issue.4, pp.341-346, 2006.
DOI : 10.2515/therapie:2006063

L. Ameye and W. Chee, Osteoarthritis and nutrition. From nutraceuticals to functional foods: a systematic review of the scientific evidence, Arthritis Research & Therapy, vol.8, issue.4, p.127, 2006.
DOI : 10.1186/ar2016

J. Clayton, Nutraceuticals in the management of osteoarthritis, Orthopedics, vol.30, pp.624-629, 2007.

L. Darlington and T. Stone, Antioxidants and fatty acids in the amelioration of rheumatoid arthritis and related disorders, British Journal of Nutrition, vol.61, issue.03, pp.251-269, 2001.
DOI : 10.1016/0024-3205(91)90156-6

C. Deal and R. Moskowitz, NUTRACEUTICALS AS THERAPEUTIC AGENTS IN OSTEOARTHRITIS, Rheumatic Disease Clinics of North America, vol.25, issue.2, pp.379-395, 1999.
DOI : 10.1016/S0889-857X(05)70074-0

H. Hauselmann, Nutripharmaceuticals for osteoarthritis, Best Practice & Research Clinical Rheumatology, vol.15, issue.4, pp.595-607, 2001.
DOI : 10.1053/berh.2001.0176

J. Zochling, L. March, H. Lapsley, M. Cross, K. Tribe et al., Use of complementary medicines for osteoarthritis--a prospective study, Annals of the Rheumatic Diseases, vol.63, issue.5, pp.549-554, 2004.
DOI : 10.1136/ard.2003.010637

M. Rayman and D. Pattison, Dietary manipulation in musculoskeletal conditions, Best Practice & Research Clinical Rheumatology, vol.22, issue.3, pp.535-561, 2008.
DOI : 10.1016/j.berh.2007.12.010

A. Wertheimer, The defined daily dose system (DDD) for drug utilization review, Hosp Pharm, vol.21, pp.233-234, 1986.

N. Moore, H. Diris, K. Martin, R. Viale, A. Fourrier et al., NSAID Use Profiles Derived from Reimbursement Data in France, Th??rapie, vol.59, issue.5, pp.541-546, 2004.
DOI : 10.2515/therapie:2004092

D. Roggeri, C. Saramin, G. Terrazzani, M. Zusso, P. Giusti et al., Resource consumption and costs of treating pain in patients affected by cancer in a district of northeast Italy, Pharmacological Research, vol.56, issue.4, pp.329-334, 2007.
DOI : 10.1016/j.phrs.2007.08.001

A. Setty and L. Sigal, Herbal Medications Commonly Used in the Practice of Rheumatology: Mechanisms of Action, Efficacy, and Side Effects, Seminars in Arthritis and Rheumatism, vol.34, issue.6, pp.773-784, 2005.
DOI : 10.1016/j.semarthrit.2005.01.011

E. Ernst, Complementary and alternative medicine in rheumatology, Best Practice & Research Clinical Rheumatology, vol.14, issue.4, pp.731-749, 2000.
DOI : 10.1053/berh.2000.0110

C. Curtis, S. Rees, J. Cramp, C. Flannery, C. Hughes et al., Effects of n-3 fatty acids on cartilage metabolism, Proceedings of the Nutrition Society, vol.53, issue.03, pp.381-389, 2002.
DOI : 10.1146/annurev.pharmtox.38.1.97

T. Stammers, B. Sibbald, and P. Freeling, Efficacy of cod liver oil as an adjunct to non-steroidal anti-inflammatory drug treatment in the management of osteoarthritis in general practice., Annals of the Rheumatic Diseases, vol.51, issue.1, pp.128-129, 1992.
DOI : 10.1136/ard.51.1.128

M. Whitehouse, K. Rainsford, R. Taylor, and B. Vernon-roberts, Zinc monoglycerolate: A slow-release source of zinc with anti-arthritic activity in rats, Agents and Actions, vol.7, issue.Suppl. 7, pp.47-58, 1990.
DOI : 10.1007/BF02003221

A. Zoli, L. Altomonte, R. Caricchio, A. Galossi, L. Mirone et al., Serum zinc and copper in active rheumatoid arthritis: Correlation with interleukin 1? and tumour necrosis factor ?, Clinical Rheumatology, vol.2, issue.suppl 1, pp.378-382, 1998.
DOI : 10.1007/BF01450895

J. Chrubasik, B. Roufogalis, H. Wagner, and S. Chrubasik, A comprehensive review on nettle effect and efficacy profiles, Part I: Herba urticae, Phytomedicine, vol.14, issue.6, pp.423-435, 2007.
DOI : 10.1016/j.phymed.2007.03.004

C. Randall, H. Randall, F. Dobbs, C. Hutton, and H. Sanders, Randomized controlled trial of nettle sting for treatment of base-ofthumb pain, J R Soc Med, vol.93, pp.305-309, 2000.

B. Kurz, B. Jost, and M. Schunke, Dietary vitamins and selenium diminish the development of mechanically induced osteoarthritis and increase the expression of antioxidative enzymes in the knee joint of STR/1N mice. Osteoarthritis Cartilage, pp.119-126, 2002.

P. Canter, B. Wider, and E. Ernst, The antioxidant vitamins A, C, E and selenium in the treatment of arthritis: a systematic review of randomized clinical trials, Rheumatology, vol.46, issue.8, pp.1223-1233, 2007.
DOI : 10.1093/rheumatology/kem116

J. Hill and H. Bird, FAILURE OF SELENIUM-ACE TO IMPROVE OSTEOARTHRITIS, Rheumatology, vol.29, issue.3, pp.211-213, 1990.
DOI : 10.1093/rheumatology/29.3.211